loadpatents
name:-0.015488147735596
name:-0.016013145446777
name:-0.0067629814147949
Karim; Riyez Patent Filings

Karim; Riyez

Patent Applications and Registrations

Patent applications and USPTO patent grants for Karim; Riyez.The latest application filed is for "antibody to gdf8 and uses thereof".

Company Profile
1.13.11
  • Karim; Riyez - North Andover MA
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Antibody to GDF8 and uses thereof
Grant 10,189,896 - LaVallie , et al. Ja
2019-01-29
Antibody To Gdf8 And Uses Thereof
App 20180265578 - LaVallie; Edward Roland ;   et al.
2018-09-20
Method for treating muscle wasting syndrome using antagonist antibodies against GDF-8
Grant 9,926,368 - Walsh , et al. March 27, 2
2018-03-27
Antibody to GDF8 and uses thereof
Grant 9,850,301 - LaVallie , et al. December 26, 2
2017-12-26
Antibody To Gdf8 And Uses Thereof
App 20170145084 - LaVallie; Edward Roland ;   et al.
2017-05-25
Antibody to GDF8 and uses thereof
Grant 9,409,981 - LaVallie , et al. August 9, 2
2016-08-09
Antagonist Antibodies Against Gdf-8
App 20150152176 - Walsh; Frank S. ;   et al.
2015-06-04
Method for treating sarcopenia using antagonist antibodies against GDF-8
Grant 8,956,608 - Walsh , et al. February 17, 2
2015-02-17
Antagonist Antibodies against GDF-8 and Uses in Treatment of ALS and Other GDF-8 Associated Disorders
App 20140086920 - Walsh; Frank S. ;   et al.
2014-03-27
Antibody To Gdf8 And Uses Thereof
App 20140023638 - LaVallie; Edward Roland ;   et al.
2014-01-23
Method for treating cachexia using antagonist antibodies against GDF-8
Grant 8,496,934 - Walsh , et al. July 30, 2
2013-07-30
Method For Treating Cachexia Using Antagonist Antibodies Against Gdf-8
App 20130156767 - Walsh; Frank S. ;   et al.
2013-06-20
Antibody to GDF8 and uses thereof
Grant 8,415,459 - LaVallie , et al. April 9, 2
2013-04-09
Polynucleotides encoding antagonist antibodies against GDF-8
Grant 8,372,625 - Walsh , et al. February 12, 2
2013-02-12
Method for treating muscular dystrophy using antagonist antibodies against GDF-8
Grant 8,349,327 - Walsh , et al. January 8, 2
2013-01-08
Antagonist Antibodies Against Gdf-8 And Uses In Treatment Of Als And Other Gdf-8 Associated Disorders
App 20120016106 - Walsh; Frank S. ;   et al.
2012-01-19
Antagonist Antibodies Against Gdf-8 And Uses In Treatment Of Als And Other Gdf-8 Associated Disorders
App 20120003212 - WALSH; FRANK S. ;   et al.
2012-01-05
Antagonist antibodies against GDF-8 and uses in treatment of ALS and other GDF-8 associated disorders
Grant 7,910,107 - Walsh , et al. March 22, 2
2011-03-22
Antagonist antibodies against GDF-8
Grant 7,888,486 - Walsh , et al. February 15, 2
2011-02-15
Antagonist Antibodies Against Gdf-8 And Uses In Treatment Of Als And Other Gdf-8 Associated Disorders
App 20090285827 - Walsh; Frank S. ;   et al.
2009-11-19
Antibody To Gdf8 And Uses Thereof
App 20090148436 - LaVallie; Edward Roland ;   et al.
2009-06-11
Antagonist antibodies against GDF-8 and uses in treatment of ALS and other GDF-8-associated disorders
App 20070087000 - Walsh; Frank S. ;   et al.
2007-04-19

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed